Opportunity for more nuanced approach
Lenvatinib promising, trials ongoing
Postsurgery chemo for certain head and neck cancers
Extends the benefits of NSM to more patients and improves outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Skilled team provides advanced surgical interventions
A recent clinical trial tested neoadjuvant therapies
Choroid lesions indicate systemic disease
Safe, effective, welcome option
Precision therapy for refractory disease now FDA approved
Preop rad therapy can offer reduced treatment duration, improved long-term functioning
Advertisement
Advertisement